glutathione synthase drug inhibitor

glutathione synthase drug inhibitor Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Cysteine metabolic circuitries: druggable targets

Name: glutathione synthase drug inhibitor Depletion and Stalwart Anticancer Activity of Metallotherapeutics Inducing Programmed Cell Death: Opening a New Window for Cancer Therapy Cysteine metabolic circuitries: druggable targets
Brand: www.ohotnichi-sezoni.com
SKU: 70212977735
Price: 21.00 USD
Availability: InStock
Rating: 4.2313 (10 reviews)

Cysteine metabolic circuitries: druggable targets in cancer British Journal of Cancer Impaired Glutathione Synthesis in Neurodegeneration GLUTATHIONE SYNTHESIS PMC Drugs and substances that affect the GSH GPX4 axis associated with Download Scientific Diagram Frontiers Glutathione: new roles in redox signaling for an old antioxidant

SKU: 70212977735 · From www.ohotnichi-sezoni.com

4.2

USD21.00 USD55.00

Pay in 4 interest-free payments of $5.25 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 6 - Aug 11

Description

Slides were then incubated overnight at 4C with anti-4-hydroxynonenol (4-HNE) primary antibody (Cat# ab46545, AbCam) at a concentration of 1:300 in 3% goat serum in TBS with 0.5% Tween

Circ Res 92:546553

A continuacin se comentar brevemente la vinculacin existente entre los niveles de GSH y determinadas patologas

The activity of -GCL depends primarily on the substrates and is inhibited by GSH

The standard therapeutic dose is 10mg per injection, though dosing is personalized based on your metabolic profile, activity level, and treatment objectives